MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-43-0001857
Balaark Pharmaceuticals Private Limited
Balaark Pharmaceuticals Private Limited - pharma in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.7 Cr
▲ 5% YoY
Net profit · FY 2025
₹14.3 Lakh
Net margin 5.3%
EBITDA · FY 2025
₹22.81 Lakh
EBITDA margin 8.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹39 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Balaark Pharmaceuticals Private Limited
Data last updated:
Balaark Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 October 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51101PN2011PTC156875. Its GSTIN is 09AAECB7491B1ZO (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Archana Singh and Anil Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.7 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹14.3 Lakh (net margin 5.3%) and EBITDA of ₹22.81 Lakh (EBITDA margin 8.4%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 8% over five years.
As per MCA filings, the company has open charges of ₹39 Lakh on record.
Balaark Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-43-0001857). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51101PN2011PTC156875
Registration Number 156875
Incorporation Date 17 October 2011
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-43-0001857
CIN history
Balaark Pharmaceuticals has one previous CIN (Corporate Identification Number): U51101UP2011PTC047011. The current CIN is U51101PN2011PTC156875, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51101PN2011PTC156875 | Current |
| U51101UP2011PTC047011 | Previous |
Recognitions & Rankings of Balaark Pharmaceuticals
Contact details
Balaark Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHd – 145 Sr No 133(P) Cts No 4944 Magarpatta Road, Kirtane Baugh Magarpatta Hadapsar, Pune, Maharashtra, India – 411028
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Balaark Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Balaark Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Balaark Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Balaark Pharmaceuticals Private Limited, buy the company report.
Financials of Balaark Pharmaceuticals Private Limited
FY 2025 filings availableBalaark Pharmaceuticals Private Limited reported revenue of ₹2.7 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹2.7 Cr ▲ 5%
Net profit · FY 2025
₹14.3 Lakh margin 5.3%
EBITDA · FY 2025
₹22.81 Lakh margin 8.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 14%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 6%
5 years · compounded
▲ 3%
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 5% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.81 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.3 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.4% | ||||
| Net Profit Margin | 5.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Balaark Pharmaceuticals Private Limited, buy the company report.
Board of directors of Balaark Pharmaceuticals Private Limited
Balaark Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Singh | Director | 17 Oct 2011 | 15 Years 0 Months | Current |
| Anil Arora | Director | 16 Aug 2019 | 7 Years 2 Months | Current |
| Neelam Singh | Director | 31 Aug 2013 | 13 Years 1 Months | Current |
Peer comparison
Balaark Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Roris Pharmaceuticals Private Limited | ₹2.71 Cr (FY 2025) | -8.0% | Jaipur, Rajasthan, India | |||
| Unimac Pharmaceutical Private Limited | ₹2.71 Cr (FY 2025) | 28.0% | New Delhi, Delhi, India | |||
| Medtabs Pharma Private Limited | ₹2.71 Cr (FY 2024) | 40.0% | Satara, Maharashtra, India | |||
| Proficon Medisol Private Limited | ₹2.71 Cr (FY 2025) | -45.0% | Delhi, India | |||
| Balaark Pharmaceuticals Private Limitedthis company | ₹2.7 Cr (FY 2025) | ₹14.3 Lakh | 5.3% | 5.0% | Pune, Maharashtra, India | |
| Gmbell Healthcare (India) Private Limited | ₹2.7 Cr (FY 2023) | 6.0% | Ahmedabad, Gujarat, India | |||
| Spark Healthcare Private Limited | ₹2.7 Cr (FY 2025) | 17.0% | Lucknow, Uttar Pradesh, India | |||
| Bemedica Health Care Limited | ₹2.69 Cr (FY 2022) | 7.0% | Ernakulam, Kerala, India |
To see the full peer comparison of Balaark Pharmaceuticals Private Limited, buy the company report.
Auditor
Balaark Pharmaceuticals Private Limited is audited by GUPTA & PANDEY for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA & PANDEY | FY 2019 | 019460C |
Shareholding
The shareholding of Balaark Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Balaark Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹39 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Jan 2019 | 100239925 | Others | ₹39 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Balaark Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Balaark Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Balaark Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECB7491B1ZO | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Balaark Pharmaceuticals Private Limited, buy the company report.
Recent activity
Balaark Pharmaceuticals Private Limited has 5 board changes on record since 2011: 3 appointments and 2 cessations. The latest: Savita Arora ceased to be Additional Director on 31 Jul 2020.
AGM
Balaark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Balaark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Savita Arora ceased to be Additional Director.
Appointed
Anil Arora was appointed as Director.
Charges
A charge with Others amounted to Rs. 39.00 Lakh with Charge ID 100239925 was registered on 31 Jan 2019.
Ceased
Manoj Sharma ceased to be Director.
Appointed
Neelam Singh was appointed as Director.
Appointed
Archana Singh was appointed as Director.
Incorporation
17 Oct 2011
Balaark Pharmaceuticals Private Limited was registered on 17 Oct 2011 with Roc Pune & aged 15 years 8 days as per MCA records.
Frequently asked questions
Balaark Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 October 2011 (15+ years old) and is registered under CIN U51101PN2011PTC156875.
Balaark Pharmaceuticals has 3 current directors:
- Archana Singh - Director
- Anil Arora - Director
- Neelam Singh - Director
The latest financial statements of Balaark Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Balaark Pharmaceuticals is 09AAECB7491B1ZO, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Balaark Pharmaceuticals is U51101PN2011PTC156875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Balaark Pharmaceuticals was incorporated on 17 October 2011, making it 15+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Balaark Pharmaceuticals by revenue are Roris Pharmaceuticals Private Limited, Unimac Pharmaceutical Private Limited, Medtabs Pharma Private Limited, Proficon Medisol Private Limited, Gmbell Healthcare (India) Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Savita Arora ceased to be Additional Director on 31 Jul 2020. Anil Arora was appointed as Director on 16 Aug 2019. Manoj Sharma ceased to be Director on 15 Oct 2014. Balaark Pharmaceuticals has 5 board changes on record in total.
Yes, Balaark Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-43-0001857).
The registered office of Balaark Pharmaceuticals is at Hd – 145 Sr No 133P Cts No 4944 Magarpatta Road, Kirtane Baugh Magarpatta Hadapsar, Pune, Maharashtra, India – 411028.
Balaark Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.